Overview

Study to Assess Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-level Deep Venous Thrombosis (DVT)

Status:
Terminated
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety profile of GMI-1271 and its effect on thrombus resolution in patients with distal calf vein Deep Venous Thrombosis (DVT).
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
GlycoMimetics Incorporated
Collaborator:
University of Michigan
Treatments:
Enoxaparin
Enoxaparin sodium